Who are in the management team of Surmodics, Inc.?

Jun 22 2025 10:10 PM IST
share
Share Via
As of March 2022, the management team of Surmodics, Inc. includes Non-Executive Independent Chairman Ms. Susan Knight, President and CEO Mr. Gary Maharaj, and Independent Directors Mr. Jose Bedoya, Dr. David Dantzker, Ms. Lisa Heine, and Mr. Ronald Kalich. This team combines executive leadership with independent oversight for the company's governance and strategy.
As of March 2022, the management team of Surmodics, Inc. includes the following individuals:

- Ms. Susan Knight, who serves as the Non-Executive Independent Chairman of the Board.
- Mr. Gary Maharaj, who is the President, Chief Executive Officer, and a Director.
- Mr. Jose Bedoya, who is an Independent Director.
- Dr. David Dantzker, who is also an Independent Director.
- Ms. Lisa Heine, who serves as an Independent Director.
- Mr. Ronald Kalich, who is an Independent Director.

This team comprises a mix of executive leadership and independent directors, contributing to the governance and strategic direction of the company.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Surmodics, Inc. Hits New 52-Week High at $42.89
Nov 18 2025 04:53 PM IST
share
Share Via
Surmodics, Inc. Hits New 52-Week High of $41.72
Nov 17 2025 04:36 PM IST
share
Share Via
Surmodics, Inc. Hits New 52-Week High at USD 41.65
Nov 13 2025 04:01 PM IST
share
Share Via
Surmodics, Inc. Hits New 52-Week High at $41.20
Nov 12 2025 04:07 PM IST
share
Share Via
Is Surmodics, Inc. technically bullish or bearish?
Sep 20 2025 07:15 PM IST
share
Share Via
Is Surmodics, Inc. overvalued or undervalued?
Sep 20 2025 05:49 PM IST
share
Share Via